chartexchange

BIAFW
bioAffinity Technologies, Inc. Warrant
stockNASDAQWarrant

At CloseNov 18, 2026
0.1518USD+0.797%(+0.0012)275
Loading…
Loading…
316,649
Healthcare
Diagnostics & Research
HQ
San Antonio, TX, USA
Previous Close
$0.15
Beta
2.89
52-Week High
$0.98 2026-09-08
52-Week Low
$0.05 2026-08-10
SMA 50
$0.26
SMA 200
$0.25
Avg. Vol 10D
1,324
Avg. Vol 30D
2,692
Avg. Vol 90D
5,126
Relative Vol
0.10
4.42M
BIAFW Profile

addressing a critical need to find cancer early and treat cancer specifically bioaffinity technologies, inc. develops tests and therapies to detect and treat cancer at the cellular level. our first product, cypath® flow cytometry for lung cancer (cypath® lung), has been licensed by precision pathology services for continued development and commercial sale as a laboratory developed test. cypath® lung has the potential to dramatically increase overall diagnostic accuracy leading to increased survival, fewer unnecessary invasive procedures and lower patient anxiety and medical costs.

BIAFW Performance
PeriodPriceDateChangeBeta
1W0.152026-11-12+31.31%0.000
1M0.422026-10-22-52.82%8.557
3M0.122026-08-19+58.84%5.549
6M0.222026-05-19-10.15%5.563
1Y0.272025-11-17-25.38%2.891
2Y0.642024-11-19-69.10%—
5Y2.102022-09-01-90.58%-0.153
BIAFW Stock Summary

bioAffinity Technologies, Inc. Warrant (NASDAQ:BIAFW) stock price today is $0.20, and today's volume is 275. BIAFW is up 31.308% today. The 30 day average volume is 2,692. BIAFW market cap is $316,649 with 1.60M shares outstanding.